103 related articles for article (PubMed ID: 13066702)
1. Proguanil, the isolation of a metabolite with high antimalarial activity.
CROWTHER AF; LEVI AA
Br J Pharmacol Chemother; 1953 Mar; 8(1):93-7. PubMed ID: 13066702
[No Abstract] [Full Text] [Related]
2. Experiments with antimalarial drugs in man. V. Experiments with an active metabolite of proguanil and an active metabolite of 5943.
ROBERTSON GI
Trans R Soc Trop Med Hyg; 1957 Nov; 51(6):488-92. PubMed ID: 13496181
[No Abstract] [Full Text] [Related]
3. A metabolite of paludrine with high antimalarial activity.
CARRINGTON HC; CROWTHER AF; DAVEY DG; LEVI AA; ROSE FL
Nature; 1951 Dec; 168(4288):1080. PubMed ID: 14910643
[No Abstract] [Full Text] [Related]
4. The mode of action of proguanil and related antimalarial drugs.
RYLEY JF
Br J Pharmacol Chemother; 1953 Dec; 8(4):424-30. PubMed ID: 13115632
[No Abstract] [Full Text] [Related]
5. Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans.
Funck-Brentano C; Bosco O; Jacqz-Aigrain E; Keundjian A; Jaillon P
Clin Pharmacol Ther; 1992 May; 51(5):507-12. PubMed ID: 1587064
[TBL] [Abstract][Full Text] [Related]
6. Proguanil polymorphism does not affect the antimalarial activity of proguanil combined with atovaquone in vitro.
Edstein MD; Yeo AE; Kyle DE; Looareesuwan S; Wilairatana P; Rieckmann KH
Trans R Soc Trop Med Hyg; 1996; 90(4):418-21. PubMed ID: 8882194
[TBL] [Abstract][Full Text] [Related]
7. Action of proguanil and its metabolite on neuromuscular and synaptic transmission.
DALLEMAGNE MJ; PHILIPPOT E
Br J Pharmacol Chemother; 1955 Jun; 10(2):147-52. PubMed ID: 14389651
[No Abstract] [Full Text] [Related]
8. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
[TBL] [Abstract][Full Text] [Related]
9. Formation of the diuretic chlorazanil from the antimalarial drug proguanil--implications for sports drug testing.
Thevis M; Geyer H; Thomas A; Tretzel L; Bailloux I; Buisson C; Lasne F; Schaefer MS; Kienbaum P; Mueller-Stoever I; Schänzer W
J Pharm Biomed Anal; 2015 Nov; 115():208-13. PubMed ID: 26226108
[TBL] [Abstract][Full Text] [Related]
10. The potentiation of the antimalarial activity of chloroguanide by p-aminobenzoic acid competitors.
GREENBERG J
J Pharmacol Exp Ther; 1949 Oct; 97(2):238-42. PubMed ID: 15391935
[No Abstract] [Full Text] [Related]
11. Polymorphic oxidative metabolism of proguanil in a Nigerian population.
Bolaji OO; Sadare IO; Babalola CP; Ogunbona FA
Eur J Clin Pharmacol; 2002 Nov; 58(8):543-5. PubMed ID: 12451432
[TBL] [Abstract][Full Text] [Related]
12. Experiments with antimalarial drugs in man. IV. An experiment to investigate the prophylactic value of proguanil against a strain of Plasmodium falciparum known to be resistant to therapeutic treatment.
DAVEY DG; ROBERTSON GI
Trans R Soc Trop Med Hyg; 1957 Sep; 51(5):463-6. PubMed ID: 13468008
[No Abstract] [Full Text] [Related]
13. Correlation between proguanil and metabolites in plasma and saliva.
Alexander C; Nathwani D; Zimbler N; Taylor RB
J Antimicrob Chemother; 1995 Dec; 36(6):1113-5. PubMed ID: 8821621
[No Abstract] [Full Text] [Related]
14. High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu.
Kaneko A; Kaneko O; Taleo G; Björkman A; Kobayakawa T
Lancet; 1997 Mar; 349(9056):921-2. PubMed ID: 9093256
[No Abstract] [Full Text] [Related]
15. The inhibitory action of some antimalarial drugs and related compounds on the hexokinase of yeast and of Plasmodium berghei.
FRASER DM; KERMACK WO
Br J Pharmacol Chemother; 1957 Mar; 12(1):16-23. PubMed ID: 13413145
[TBL] [Abstract][Full Text] [Related]
16. Experiments with antimalarial drugs in man. I. The protective effect of proguanil (paludrine) against an East African strain of Plasmodium falciparum transmitted by Anopheles gambiae.
THOMAS AT; ROBERTSON GI; DAVEY DG
Trans R Soc Trop Med Hyg; 1953 Jul; 47(4):338-45. PubMed ID: 13090297
[No Abstract] [Full Text] [Related]
17. Atovaquone-proguanil for prophylaxis and treatment of malaria.
Marra F; Salzman JR; Ensom MH
Ann Pharmacother; 2003 Sep; 37(9):1266-75. PubMed ID: 12921511
[TBL] [Abstract][Full Text] [Related]
18. Trends in antimalarial prescriptions in Australia 2002 to 2005.
Leggat PA
J Travel Med; 2008; 15(5):302-6. PubMed ID: 19006502
[TBL] [Abstract][Full Text] [Related]
19. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
[TBL] [Abstract][Full Text] [Related]
20. Modern antimalarial therapy.
PFEIFFER CC
Mod Hosp; 1952 Aug; 79(2):106-8. PubMed ID: 12992919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
